Ifetroban
- Generic Name
- Ifetroban
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H32N2O5
- CAS Number
- 143443-90-7
- Unique Ingredient Identifier
- E833KT807K
- Background
Ifetroban has been used in trials studying the treatment of Skin Diseases, Autoimmune Diseases, Pathologic Processes, Scleroderma, Limited, and Scleroderma, Diffuse, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Oral Ifetroban in Patients with Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
Recruiting
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Drug: Ifetroban SodiumDrug: Placebo
- First Posted Date
- 2022-10-07
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Cumberland Pharmaceuticals
- Target Recruit Count
- 128
- Registration Number
- NCT05571059
- Locations
- 🇺🇸
Temple University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸Baylor University Medical Center, Dallas, Texas, United States
🇺🇸Premier Pulmonary Critical Care and Sleep Medicine, Denison, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath